BioSystOmics is a systems pharmacology and systems biology Research & Development organization. We provide in-silico products and data analysis services to pharmaceutical and biotechnology industry. Our in-silico tools could be utilized to arrive at key efficacy and safety decisions of drugs without actually testing them in clinic. Our products are designed to provide an integrated view by combining various physiological, biochemical and genomic data sets. We can revitalize your R&D portfolio through introducing the rational and in-depth network analysis capabilities. We can help you in developing the novel therapeutic approaches to treat complex diseases like heart failure, Alzheimer disease, diabetes, and cancer.